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Abstract
Background: The objective of this meta-analysis was to compare the efficacy and safety of patient-controlled
epidural analgesia (PCEA) and patient-controlled intravenous analgesia (PCIA) in postoperative analgesia of spinal
fusion surgery.
Methods: Potential academic articles were identified from the Cochrane Library, Medline (1966–2015.5), PubMed
(1966–2015.5), Embase (1980–2015.5) and ScienceDirect (1966–2015.5). Gray studies were identified from the
references of the included literature. Randomized controlled trials (RCTs) involving PCEA and PCIA after spinal fusion
were included. Two independent reviewers performed independent data abstraction. I2 statistic was used to assess
heterogeneity. Fixed or random effects model was used for meta-analysis.
Results: Eight RCTs met the inclusion criteria. There was a better analgesic effect in patients with PCEA for
postoperative VAS on the first day (P = 0.0005) and second day (P = 0.006). The patients with PCEA had a higher
incidence of pruritus (P = 0.02) and paresthesia (P = 0.03) after surgery than those with PCIA. There was no
statistically significant difference in postoperative VAS on the third day (P = 0.15), nausea (P = 0.74) or emesis
(P = 0.37) between the two groups.
Conclusions: After spinal fusion, the patients with PCEA have similar analgesic efficacy during the three
postoperative days and a higher incidence of pruritus and paresthesia than those with PCIA. Due to the limited
quality and data of the evidence currently available, more high-quality randomized controlled trials are required.
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Background
Low back pain (LBP) is an increasing clinical com-
plaint in modern society; the condition affects up to
80 % of the population during their lifetime [1]. LBP
is known to be associated with degenerative spinal
diseases [2] such as lumbar disc herniation [3], lumbar
spondylolisthesis [4], and adolescent idiopathic scoliosis
[5]. Spinal fusion has been applied in the treatment of
various degenerative spinal diseases [6]. Furthermore, this
trend is being further enhanced owing to the development
of surgical techniques and spinal instrumentation.
Spinal fusion aims to alleviate pain by eliminating the
painful spinal motion segments. Many patients who
receive successful spinal fusion surgery obtain good
outcomes [7–9].
However, major spinal surgeries involving spinal fusion
cause severe postoperative pain, which most often lasts
for the first three postoperative days [10, 11]. Because
postoperative pain control is difficult and complex, it
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Table 1 The main characteristics of included studies
Disease Patient-controlled epidural analgesia (PCEA) Patient-controlled intravenous analgesia (PCIA)
N(M/F) Average
age
Drugs POC N(M/F) Average
age
Drugs
Joshua 2013 [18] AIS 44 NM Bupivacaine Fentanyl 5 cm up to the middle
of fused centrum
22 NM Morphine
Kluba 2010 [19] IDD 29 (14/15) 57 Ropivacaine Sufentanil 3 cm up to the middle
of fused centrum
23 (14/9) 62 Piritramid
Gauger 2009 [17] AIS 19 (0/19) 15.1 Bupivacaine
Hydromorphone
3–5 cm up to middle
of fused centrum
19 (4/15) 14.7 Hydromorphone
Schenk 2006 [23] LS 28 (15/13) 42 Ropivacaine Sufentanil At the middle of
fused centrum
30 (21/9) 50 Morphine
Fisher 2003 [22] IDD 36 (17/19) 50 Fentanyl Bupivacaine
Epivacaine
10 cm up to the middle
of fused centrum
38 (15/23) 51 Fentanyl
Cassady 2000 [20] AIS 17 (2/15) 14.6 Bupivacaine Epivacaine NM 16 (3/13) 14.4 Morphine sulfate
Coben 1997 [21] IDD 21 45 Morphine sulfate NM 21 45 Morphine sulfate
Bupivacaine
Johnson 1989 [24] IDD 29 (21/8) 39 Fentanil Morphine
sulfate
2–3 cm up to middle
of fused centrum
13 (8/5) 39 Morphine sulfate
N(M/F) numbers(male/female), POC position of catheter, AIS adolescent idiopathic scoliosis, IDD intervertebral disc degeneration, LS lumbar spodylolithesis
Fig. 1 Flowchart of the study selection process
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is an important aspect of patient care after spinal fu-
sion [12, 13]. Apfelbaum et al. [14] reported that
more than 70 % of patients experienced moderate to se-
vere postoperative pain, and almost 25 % of patients had
adverse effects with postoperative analgesia. Effective
postoperative analgesia could not only improve patients’
satisfaction, but also reduce the incidence of postoperative
complications and shorten the length of hospitalization
[15, 16]. A multimodal approach is used for pain manage-
ment, including patient-controlled intravenous analgesia
(PCIA), patient-controlled epidural analgesia (PCEA), opi-
oid medication, benzodiazepines, and oral acetaminophen.
PCEA plays a direct role in the near operative region,
so the analgesic effect of PCEA is clear and fast. PCIA
acts on a systemic level via intravenous analgesia drugs,
so the analgesic effect of PCIA lasts substantially lon-
ger. Although both forms of analgesia are often used in
spinal fusion, controversies over their efficacy and
safety still exist. For patients who undergo spinal fu-
sion, there are no systematic studies or reviews deter-
mining the difference between PCEA and PCIA. The
purpose of the present meta-analysis is to compare the
efficacy and safety of PCEA versus PCIA in patients
with spinal fusion surgery from randomized controlled
trials (RCTs).
Methods
Inclusion and exclusion criteria
RCTs were included if the following criteria were met:
(1) Study design: RCT; (2) Study object: patients with
spinal fusion surgery; (3) Postoperative analgesic inter-
ventions: Patients in the PCEA group received PCEA;
analgesic drugs could include the single use of a local
anesthetic drug or the combined use of opioids. Patients
in the PCIA group received PCIA; analgesic drugs could
include the single use of a local anesthetic drug or the
combined use of opioids. Analgesic drugs may include
the use of opioids or combined use of other drugs; (4)
Outcome measures: The VAS scores of patients with
spinal fusion on the first, second and third postoperative
days during postoperative analgesia; Adverse effects in-
cluding nausea, vomiting, skin itch, and paresthesia.
RCTs were excluded if (1) The combined application of
other measures besides analgesic interventions could
have an impact on the final analysis; (2) the patients re-
ceived spinal nonfusion; (3) the literature contained no
associated data.
Fig. 2 The summary of bias risk of included studies
Fig. 3 Forest plot of VAS score at post-operative first day between PCEA and PCIA
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Search strategy
PubMed, Medline, EMBase, Cochrane library, Science
Direct and Web of Science were searched in March
2015 for RCTs involving PCEA and PCIA in the
management of pain relief after spinal fusion. The
search terms were as follows: epidural analgesia;
intravenous analgesia; spinal fusion. No restrictions
were imposed on language. The reference lists of all
the eligible studies and relevant reviews were exam-
ined to identify any initially omitted studies. The in-
cluded studies were published in a peer-reviewed
journal as a full article, excluding the gray literature
and conference proceedings.
Quality assessment and data extraction
Two reviewers independently evaluated the bias risk of
RCTs included in the study according to the RCT bias
risk assessment tools of the Cochrane Handbook Ver-
sion 5.1. For each eligible study, both reviewers extracted
all the relevant data independently. Any disagreement
was resolved by discussion; when no consensus could be
achieved, a third reviewer acted as the adjudicator and
made the final decision. Whenever necessary, reviewers
contacted the authors of the studies for missing data or
further information. The following data were extracted:
(1) demographic data of participants; (2) indications for
spinal fusion; (3) analgesic drugs, position of the cath-
eter, analgesic efficacy evaluation index, and the inci-
dence of adverse reaction after analgesia; (4) any other
outcomes as mentioned in individual studies were
considered for inclusion. In studies in which data were
incomplete or unclear, attempts were made to contact
the investigators for clarification.
Data analysis and statistical methods
The meta-analysis was conducted with Review Manager
software 5.2 for Windows (RevMan Version 5.2; The
Nordic Cochrane Center, The Cochrane Collaboration,
Copenhagen, Denmark). Statistical heterogeneity was
assessed for each study, using a standard Chi square test,
with significance set at a P value of 0.1, which was
measured by the I2 statistic. When I2 > 50 %, P < 0.1
was considered to be significant heterogeneity. There-
fore, a random-effects model was applied for data
analysis. A fixed-effects model was used when no sig-
nificant heterogeneity was found. In cases of signifi-
cant heterogeneity, subgroup analysis was performed
to investigate sources. For continuous outcomes,
mean differences (MDs) and 95 % confidence intervals
(CIs) were presented. Relative risk (RR) and 95 % CIs were
calculated for dichotomous data.
Results
Literature search
A total of 372 potential studies were identified using the
first search strategy. 67 reports were excluded during
screening of titles and 41 reports were excluded after
screening of abstracts. Finally, 364 reports were excluded
according to the eligibility criteria. No additional studies
were obtained after the reference review. After careful
full-text evaluation, eight independent RCTs [17–24]
with 482 patients were included in the current meta-
analysis as indicated by the flowchart in Fig. 1.
Study characteristics
The main characteristics of the included studies are re-
ported in Table 1. The sample size of included studies
Fig. 4 Forest plot of VAS score at post-operative second day between PCEA and PCIA
Fig. 5 Forest plot of VAS score at post-operative third day between PCEA and PCIA
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ranged from 33 to 74 patients. Statistically similar base-
line characteristics were observed between PCEA and
PCIA groups, including age, sex ratio and so on. Drug
and dosage varied among studies.
Risk of bias assessment
The quality of the included studies according to the
Cochrane Handbook for Systematic Review of Interven-
tions is reported in Fig. 2. Randomization was not clear
for one RCT [20]. Adequate concealment of allocation
was clear for three studies [21–23]. Three included studies
[21–23] stated blinding.
Outcomes for meta-analysis
Postoperative visual analogue scale (VAS) scores
A VAS with a range from 0 to 10 was used to assess sub-
jective pain intensity. The VAS score was used to evaluate
the postoperative pain condition of patients who received
PCEA and PCIA in all included studies. VAS scores on
the first, second and third postoperative days were
conducted to meta-analysis respectively.
VAS score on first postoperative day
Seven included studies stated VAS score on the first
postoperative day [17–23]. There was no significant
heterogeneity (χ2 = 3.54, df = 6, I2 = 0 %, P =0.72; Fig. 3).
The pooled results indicated that the analgesic effect
of PCEA was better than that of PCIA; there was a
statistically significant difference between the two groups
(MD= −0.47, 95 % CI:−0.74 to−0.20, P =0.0005).
VAS score on second postoperative day
Five studies reported VAS score on the second postopera-
tive day [17, 20–23]. There was no significant heterogeneity
(χ2 = 6.47, df = 4, I2 = 38 %, P =0.17; Fig. 4). The pooled re-
sults indicated that the analgesic effect of PCEA was better
than that of PCIA; there was a statistically significant
difference between the two groups (MD = −0.66, 95 %
CI:−1.14 to−0.19, P =0.006).
VAS score on third postoperative day
Five included studies assessed VAS score on the third
postoperative day [17, 19, 21–23]. There was significant
heterogeneity (χ2 = 10.24, df = 4, I2 = 61 %, P =0.04;
Fig. 5). The pooled results indicated that the analgesic
effect of PCEA was better than that of PCIA; there
was no significant difference between the two groups
(MD = −0.58, 95 % CI:−1.38 to 0.21, P =0.15).
Adverse reactions
Nausea
Three studies reported postoperative nausea after ap-
plication of PCEA or PCIA [18, 21, 24]. There was
no significant heterogeneity (χ2 = 3.88, df = 2, I2 = 49 %,
P =0.14; Fig. 6). Pooled results demonstrated that the inci-
dence of postoperative nausea showed no significant dif-
ference between the two groups (RR = 1.05, 95 % CI: 0.79
to 1.40, P =0.74).
Emesis
Two studies showed postoperative emesis after applica-
tion of PCEA and PCIA [17, 18]. There was no signifi-
cant heterogeneity (χ2 = 1.28, df = 1, I2 = 22 %, P =0.26;
Fig. 7). Pooled results demonstrated that the incidence
of postoperative emesis showed no significant difference
between the two groups (RR = 0.80, 95 % CI: 0.48 to
1.31, P =0.37).
Fig. 6 Forest plot of postoperative nausea between PCEA and PCIA
Fig. 7 Forest plot of postoperative emesis between PCEA and PCIA
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Pruritus
Five studies documented postoperative pruritus after
application of PCEA and PCIA [18, 20–22, 24]. There
was no significant heterogeneity (χ2 = 2.58, df = 4, I2 = 0 %,
P =0.63; Fig. 8). Pooled results demonstrated that the
incidence of postoperative pruritus showed a significant
difference between the two groups (RR = 1.53, 95 % CI:
1.08 to 2.61, P =0.02).
Paresthesias
Four studies reported postoperative paresthesias after
application of PCEA and PCIA [17–19, 22]. There was
no significant heterogeneity (χ2 = 2.05, df = 3, I2 = 0 %,
P =0.56; Fig. 9). Pooled results demonstrated that the
incidence of postoperative paresthesias showed a sig-
nificant difference between the two groups (RR = 3.34,
95 % CI: 1.12 to 9.98, P =0.03).
Discussion
Patients’ postoperative satisfaction and functional re-
covery determine the overall efficacy of spinal fusion
surgery. Effective analgesia can reduce or even elimin-
ate pain so that patients achieve better results after re-
habilitation. Therefore, it is imperative to choose the
appropriate postoperative pain management strategy
[25, 26]. The most important findings of the present
meta-analysis are that the application of PCEA does
not more effectively relieve in three postoperative day
pain as compared to PCIA, meanwhile increasing the
incidence of some complications such as pruritus and
paresthesia.
Eight RCTs were reviewed in the current meta-
analysis. Although the quality of the included studies
was relatively high, there were still methodological weak-
nesses which should be taken into consideration. The
blinding of four studies was not adequate; thus, detec-
tion bias may influence the results. Complete baseline
data was shown in all literature. Due to the small sizes
of the included studies, reviewers failed to conduct sub-
group analysis to find the source of heterogeneity,
though there was significant heterogeneity in some out-
comes between groups.
Present meta-analysis showed that the analgesic effect
on patients in the PCEA group was better than that in
the PCIA group on the first and second postoperative
days, but there was no significant difference in the anal-
gesic effect on the two groups on the third postoperative
day. Although there were significant differences in VAS
score between two groups at the first and second post-
operative day, the MD and 95 % CI were very small
(MD = −0.47, 95 % CI:−0.74 to−0.20 and MD = −0.66,
95 % CI:−1.14 to−0.19 respectively). The extreme of the
95 % CI and this little MD were thus quite unlikely to
be the actual difference between PCEA and PCIA. We
should consider these when analysing the present findings.
There was no difference in analgesic effect between PCEA
and PCIA group at third postoperative day. There was no
substantial difference of pain-relief between the PCEA
and PCIA or at least that the demonstrated difference of
pain relieve associated with two analgesic methods was so
small that it could not be clinically relevant. These results
were not consistent with some researches [27, 28]. In
Fig. 8 Forest plot of postoperative pruritus between PCEA and PCIA
Fig. 9 Forest plot of postoperative paresthesias between PCEA and PCIA
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theory, PCEA seems to be an ideal method for postopera-
tive pain control; it could be demonstrated to have a bet-
ter postoperative analgesic effect in many common
operations such as abdominal and gynecological surgeries
[29, 30]. PCEA could possess a more immediate analgesic
mechanism, thus reducing the use of opioids [21].
The diagnosis of patients received spinal fusion included
scoliosis and other spinal degenerative diseases such as
lumbar spondylolisthesis and lumbar spinal stenosis. The
results demonstrated that there was a higher incidence of
pruritus and paresthesia in patients with PCEA than those
with PCIA (RR = 1.53, 95 % CI: 1.08 to 2.61, P =0.02 and
RR = 3.34, 95 % CI: 1.12 to 9.98, P =0.03 respectively). But
there was no significant difference in nausea and vomiting
experienced between the PCEA and PCIA groups (RR =
1.05, 95 % CI: 0.79 to 1.40, P =0.74 and RR = 0.80, 95 %
CI: 0.48 to 1.31, P =0.37 respectively). Nausea and vomit-
ing are common side effects in the process of analgesic
therapy [31]. Lumbar spinal stenosis could potentially in-
crease the risk of patients with PCEA-induced paresthesia
and motor palsy. Kluba study [19] and Fisher study [22]
demonstrated that there was significantly higher incidence
of paresthesia compared with the other studies. The use of
postoperative PCEA should be cautious after the treat-
ment of lumbar spinal stenosis and lumbar spondylolisth-
esis with spinal surgery. Only one study demonstrated
that there were no significant differences between groups
in VAS pain scores, side effects, or time to resumption of
liquid intake between PCEA and PCIA [20], and the ages
of patients in that study were lower than those of patients
in other studies.
Ethnicity, age and genetics could influence the re-
sponse to morphine; adverse reactions to analgesic drugs
could be different [32]. Some reviews demonstrated that
intravenous acetaminophen had no effect on gastrointes-
tinal motility, renal function or bone healing [33]. In
future research, subjects should be of similar age in
order to reduce age bias.
It is imperative to acknowledge several potential limi-
tations in our meta-analysis: (1) For the particularity of
the clinical operation, the sample size of each trial was
relatively small; (2) There were some differences in post-
operative analgesia drugs and dosages; (3) There were
some methodological weakness in all included RCTs. Be-
cause of the above defects and deficiencies, the pooled
estimates should be explained with caution.
Conclusion
After spinal fusion, the patients with PCEA have similar
analgesic efficacy during the three postoperative days
and a higher incidence of pruritus and paresthesia than
those with PCIA. Due to the limited quality and data of
the evidence currently available, more high-quality ran-
domized controlled trials are required.
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